Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Cell-based therapy approaches: the hope for incurable diseases.

Buzhor E, Leshansky L, Blumenthal J, Barash H, Warshawsky D, Mazor Y, Shtrichman R.

Regen Med. 2014;9(5):649-72. doi: 10.2217/rme.14.35. Review.

PMID:
25372080
2.

Human embryonic stem cells prevent T-cell activation by suppressing dendritic cells function via TGF-beta signaling pathway.

Leshansky L, Aberdam D, Itskovitz-Eldor J, Berrih-Aknin S.

Stem Cells. 2014 Dec;32(12):3137-49. doi: 10.1002/stem.1833.

3.

LifeMap Discovery™: the embryonic development, stem cells, and regenerative medicine research portal.

Edgar R, Mazor Y, Rinon A, Blumenthal J, Golan Y, Buzhor E, Livnat I, Ben-Ari S, Lieder I, Shitrit A, Gilboa Y, Ben-Yehudah A, Edri O, Shraga N, Bogoch Y, Leshansky L, Aharoni S, West MD, Warshawsky D, Shtrichman R.

PLoS One. 2013 Jul 17;8(7):e66629. doi: 10.1371/journal.pone.0066629. Print 2013.

4.

Human mesenchymal stem cells shift CD8+ T cells towards a suppressive phenotype by inducing tolerogenic monocytes.

Hof-Nahor I, Leshansky L, Shivtiel S, Eldor L, Aberdam D, Itskovitz-Eldor J, Berrih-Aknin S.

J Cell Sci. 2012 Oct 1;125(Pt 19):4640-50. doi: 10.1242/jcs.108860. Epub 2012 Jul 5.

5.

Repair of full-thickness tendon injury using connective tissue progenitors efficiently derived from human embryonic stem cells and fetal tissues.

Cohen S, Leshansky L, Zussman E, Burman M, Srouji S, Livne E, Abramov N, Itskovitz-Eldor J.

Tissue Eng Part A. 2010 Oct;16(10):3119-37. doi: 10.1089/ten.TEA.2009.0716.

PMID:
20486794

Supplemental Content

Loading ...
Support Center